# Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

> **NCT00003005** · PHASE1 · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Cordycepin
- **DRUG:** Deoxycoformycin

## Key facts

- **NCT ID:** NCT00003005
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** 2001-03
- **Final completion:** 2001-03
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003005, "Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*